Boston Partners All Cap Value Instl (BPAIX)
31.46
+0.15 (+0.48%)
USD |
Aug 05 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.80% | 1.464B | 1.05% | 37.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -417.46M | 0.51% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to provide long-term growth of capital primarily through investment in equity securities; current income is a secondary objective. The Advisor pursues the fund's objective by investing, under normal circumstances, at least 80% of its net assets (including borrowings for investment purposes) in a diversified portfolio consisting primarily of equity securities, such as common stocks of issuers across the capitalization spectrum and identified by the Adviser as having value characteristics. It may also invest up to 20% of its total assets in non U.S. dollar denominated securities. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | BPAIX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Boston Partners |
| Prospectus Benchmark Index | |
| Russell 3000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Duilio Ramallo | 17.51 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
87
-417.46M
-5.480B
Category Low
19.19B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of July 31, 2022
Performance Versus Category
As of August 05, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of August 05, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Johnson & Johnson | 3.26% | 171.11 | -0.40% |
| Bank of America Corp | 2.12% | 33.96 | 1.68% |
| AbbVie Inc | 1.99% | 138.04 | -0.63% |
| McKesson Corp | 1.87% | 346.69 | 2.63% |
| Pfizer Inc | 1.85% | 49.27 | -1.18% |
| Medtronic PLC | 1.79% | 93.28 | 0.08% |
| Fleetcor Technologies Inc | 1.76% | 226.63 | 1.62% |
| UnitedHealth Group Inc | 1.70% | 535.06 | 0.25% |
| American International Group Inc | 1.63% | 51.83 | 1.39% |
| Anthem Inc | 1.54% | 475.13 | 0.05% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | Upgrade |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| The investment seeks to provide long-term growth of capital primarily through investment in equity securities; current income is a secondary objective. The Advisor pursues the fund's objective by investing, under normal circumstances, at least 80% of its net assets (including borrowings for investment purposes) in a diversified portfolio consisting primarily of equity securities, such as common stocks of issuers across the capitalization spectrum and identified by the Adviser as having value characteristics. It may also invest up to 20% of its total assets in non U.S. dollar denominated securities. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | BPAIX |
| Equity Style | Large Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Large Value |
| Category Index | Russell 1000 Value TR USD |
| Prospectus Objective | Growth and Income |
| Fund Owner Firm Name | Boston Partners |
| Prospectus Benchmark Index | |
| Russell 3000 Value TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Duilio Ramallo | 17.51 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (8-5-22) | 1.05% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield (11-18-16) | Upgrade |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 14.45 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of April 30, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 7/1/2002 |
| Last Annual Report Date | 8/31/2020 |
| Last Prospectus Date | 3/2/2022 |
| Share Classes | |
| BPAVX | Inv |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |